An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

書誌詳細
第一著者:	Bristy, Israt Zerin
その他の著者:	Kabir, Md. Tanvir
フォーマット:	学位論文
言語:	English
出版事項:	Brac University 2021
主題:	Covid-19 Lung carcinoma Genetic mutation Chemotherapy Immunotherapy Lungs > Cancer Oncology
オンライン･アクセス:	http://hdl.handle.net/10361/15619

類似資料

Molecules associated with the development of lung cancer
著者:: Rahman, Adree, 等
出版事項: (2023)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
著者:: Shabnam, Musharrat
出版事項: (2018)

Immunotherapy in the Management of Lung Cancer
著者:: Tasnim, Humayra
出版事項: (2022)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
著者:: Paul, Pulock
出版事項: (2024)

Potential of liposomes for the treatment of lung cancer- a review
著者:: Mim, Shanzida
出版事項: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
著者:: Jeba, Joynob
出版事項: (2017)

A review on recent advances in drugs for lung cancer treatment
著者:: Noor, Fouzia
出版事項: (2024)

A review on targeted therapies for lung cancer
著者:: Ashraf, Anushey
出版事項: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
著者:: Zangmo, Thinley
出版事項: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
著者:: Tania, Umme
出版事項: (2023)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
著者:: Rahman, Sanjida
出版事項: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
著者:: Rahman, Tasnim
出版事項: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
著者:: Razna, Amrin Islam
出版事項: (2019)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
著者:: Hoque, Ismoth Ara
出版事項: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
著者:: Pial, Sazia Afrin
出版事項: (2018)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
著者:: Mukti, Roushney Fatima, 等
出版事項: (2016)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Flora, Sanzida Alam
出版事項: (2024)

Immunotherapy in the treatment of renal cancer
著者:: Shimu, Sumaya
出版事項: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
著者:: Das, Reshita
出版事項: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
著者:: Abir, Shifaty Nur
出版事項: (2024)

Lung cancer detection and classification using machine learning
著者:: Arefin, Mahbubul, 等
出版事項: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
著者:: Nandy, Aditi
出版事項: (2022)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
著者:: F. S. Amaral, André, 等
出版事項: (2017)

Current practice and approaches of immunotherapy in Cancer treatment
著者:: Khondokar, Faiza
出版事項: (2022)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A localized drug delivery approach to treat peritoneal carcinomatosis of different origins
著者:: Afrin, Sabrina
出版事項: (2023)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
著者:: Auvy, Akib Al Mahmud, 等
出版事項: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Karim, Samia Binte
出版事項: (2024)

Deep 3D convolutional neural network in early detection of Lung cancer
著者:: Hossain, Khandoker Jobayer, 等
出版事項: (2019)

A review on CRISPR-Cas system based applications in Oncology
著者:: Sadia, Mir
出版事項: (2022)

Smart biomedical device to predict lung diseases, COVID-19 and diabetes by using machine learning algorithms
著者:: Hossain, Ashraful, 等
出版事項: (2024)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
著者:: Rithin, Rafia Islam
出版事項: (2022)

Hypothesizing precise cancer treatments based on patient survival using machine learning & deep learning
著者:: Sakib, Hasibul, 等
出版事項: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
著者:: Mirza, Maisa Tasnim
出版事項: (2023)

CAR-T cell Therapy in B-cell Lymphoma
著者:: Faruk, Asef
出版事項: (2020)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
著者:: Chowdhury, Maisha Mosharrat
出版事項: (2018)

Dendritic cell vaccine for the treatment of cancer
著者:: Haque, Tanzila
出版事項: (2023)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
著者:: Monayem, Kazi Fahim
出版事項: (2024)

The uses of bacteria in cancer therapy
著者:: Saha, Shimul, 等
出版事項: (2021)

A review paper on Nanotechnology based strategies in the treatment of cancer
著者:: Rahman, Samia
出版事項: (2022)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
著者:: Raihan, Dilraj
出版事項: (2024)